Announced
Completed
Synopsis
Sentiss Pharma, a provider of pharmaceutical products of the highest quality to ophthalmic, ENT and inhalation markets, completed the acquisition of Akorn, a niche generic pharmaceutical company engaged in the development, manufacture and marketing of multi-source and branded. Financial terms were not disclosed.
Show Details & Financials
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.